Pharma & Biotech

While Aura Biosciences shares have been mired in a months-long downtrend, market analysts maintain strikingly optimistic price targets for the...

A significant safety notification from the U.S. Food and Drug Administration has disrupted Boston Scientific's positive trajectory. The regulatory warning...

Despite showcasing an aggressive expansion strategy through product launches and partnerships, Thermo Fisher Scientific is confronting a significant crisis of...

Pharmaceutical giant Bristol-Myers Squibb is undergoing a significant strategic transformation, marked by two major developments in key international markets this...

Moderna investors have experienced significant volatility recently as the biotech company navigated both concerning safety reports and encouraging clinical developments....

After weathering months of downward pressure, Indianapolis-based pharmaceutical giant Eli Lilly is demonstrating renewed strength. A series of significant developments...

Investors in Bruker Corporation were taken by surprise when the instrument and diagnostics manufacturer announced a substantial capital raise, sending...

After a challenging period that saw its valuation cut in half, gene-editing specialist Intellia Therapeutics appears to be building a...

A landmark legal settlement has fundamentally reshaped the long-term financial outlook for pharmaceutical giant AbbVie. The company has successfully safeguarded...

ImmunityBio's stock experienced a significant boost, climbing more than 8%, following the presentation of compelling new data from its Phase...